As of May 03
| -0.04 / -3.70%|
The 2 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +332.69% increase from the last price of 1.04.
The current consensus among 2 polled investment analysts is to Buy stock in Prima BioMed Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.